Common Myths About Diabetes: What the Evidence Says

Despite being one of the most prevalent chronic diseases in the world — affecting more than 537 million people globally and more than 37 million Americans — diabetes is also one of the most misunderstood. Common myths about diabetes are pervasive in popular culture, on social media, and sometimes even in healthcare settings. These myths cause real harm: they fuel stigma that discourages people from seeking diagnosis and treatment, lead to dangerous self-management decisions, promote pseudoscientific “cures” that displace effective care, and create guilt and shame in people living with a complex metabolic condition that has far more to do with genetics and biology than personal failure. This guide examines the most common and consequential myths about diabetes and replaces each one with a clear, evidence-based answer.

Myth 1: Eating Too Much Sugar Causes Diabetes

The reality: Sugar does not directly cause diabetes. This is the most widespread myth about diabetes and also one of the most harmful, because it implies that diabetes is simply the result of personal dietary indulgence — which is both scientifically wrong and deeply stigmatizing.

Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing beta cells in the pancreas. It has nothing to do with sugar intake. It can develop in people who never consume added sugar, in infants, in elite athletes — in anyone with the relevant genetic susceptibility and whatever environmental trigger sets off the autoimmune response. No amount of dietary restriction prevents Type 1.

Type 2 diabetes develops through the pathway of insulin resistance and beta cell decline, driven by a complex interaction of genetic factors, age, physical activity, sleep quality, stress, and yes — dietary patterns. But the dietary link is not “sugar causes diabetes.” It is more nuanced: diets high in refined carbohydrates and added sugars contribute to excess caloric intake and visceral fat accumulation, which worsen insulin resistance — one of multiple pathways to Type 2 diabetes. The connection runs through caloric excess, weight gain, and fat distribution, not through sugar molecules directly. People can develop Type 2 diabetes with very low sugar intake if they have strong genetic predisposition, are highly sedentary, have poor sleep, or carry excess abdominal fat. And many people with very high sugar consumption never develop diabetes because their genetic profile and other factors protect them.

What diet does contribute to Type 2 diabetes risk is overconsumption of calories leading to visceral fat accumulation, combined with high-glycemic eating patterns that chronically overstimulate insulin secretion. Reducing added sugars and refined carbohydrates is a useful strategy — but framing diabetes as “caused by sugar” misrepresents both the disease and the people who have it.

Myth 2: Only Overweight or Obese People Get Diabetes

The reality: Body weight is a significant risk factor for Type 2 diabetes, but it is neither necessary nor sufficient. Type 1 diabetes has no association with body weight at all. And Type 2 diabetes occurs across the full spectrum of body sizes — including in people with normal BMI.

Research consistently shows that a significant proportion of people diagnosed with Type 2 diabetes — estimates range from 10 to 25 percent depending on the population studied — are at what is considered “normal” weight by BMI standards. This is particularly true in South and East Asian populations, where Type 2 diabetes risk emerges at BMI values of 23 to 25 — well below the conventional overweight threshold of 25 to 30. These individuals often have high visceral fat relative to total body fat (the “metabolically obese normal weight” or “thin-fat” phenotype), meaning their metabolic risk is not captured by BMI alone.

Conversely, many people who are significantly overweight or obese never develop Type 2 diabetes — because their beta cell reserve is sufficient, their genetic predisposition is low, or they remain metabolically healthy due to high muscle mass, regular activity, or other protective factors. Weight is one important input into diabetes risk, not the whole story, and framing diabetes as a weight-caused condition both overstates the role of body size and understates the roles of genetics, activity, and metabolic health.

Myth 3: Diabetes Is Not a Serious Condition

The reality: Diabetes is one of the leading causes of preventable death, blindness, kidney failure, and amputation in the world. It is the eighth leading cause of death in the United States and contributes to cardiovascular disease, which is the leading cause. Adults with diabetes face two to four times the cardiovascular risk of those without it. Diabetes is the leading cause of end-stage kidney disease requiring dialysis, the leading cause of preventable blindness in working-age adults, and the leading non-traumatic cause of lower limb amputation. The total burden of suffering, disability, and premature death attributable to uncontrolled diabetes is staggering. None of this makes it a hopeless condition — managed well, most people with diabetes live full, long lives — but dismissing it as a “mild” or non-serious condition is both medically inaccurate and harmful, because it reduces the motivation for the consistent management that prevents these complications. For a detailed look at the mechanisms and scope of these complications, see our guide on why blood sugar matters for long-term health.

Myth 4: People With Diabetes Cannot Eat Carbohydrates or Sweets

The reality: People with diabetes can eat carbohydrates — including some desserts and sweets — as part of a balanced, managed diet. The key is understanding how different carbohydrates affect blood sugar and making informed choices about quantity, quality, and timing.

No carbohydrate food is automatically forbidden for people with diabetes. The relevant factors are the total carbohydrate content and glycemic impact of a meal, not whether a specific food is present. A small serving of ice cream eaten after a protein-rich meal may produce a more modest blood sugar rise than a large bowl of white rice eaten alone. Context matters: the combination of foods, the total quantity, and the timing all affect glucose response.

The dietary approach recommended by the American Diabetes Association is individualized — there is no single “diabetes diet.” Low-carbohydrate diets, Mediterranean diets, plant-based diets, and other approaches all have evidence supporting their effectiveness in blood sugar management when implemented consistently. What the evidence consistently shows is the value of fiber-rich carbohydrates over refined ones, and the importance of managing total carbohydrate load — not the elimination of carbohydrates entirely. People with Type 1 diabetes using insulin can adjust their doses to cover virtually any food, though choosing lower-glycemic options makes management more predictable.

Myth 5: Type 2 Diabetes Is a Milder Form of Diabetes

The reality: Type 2 diabetes is not milder than Type 1 — it is simply a different disease with a different mechanism, different onset pattern, and different typical management approach. Both conditions, if poorly controlled over years, produce the same devastating complications: cardiovascular disease, kidney failure, retinopathy, neuropathy, and increased infection risk.

The perception that Type 2 is “milder” may stem from the fact that it typically has a slower onset, often does not require insulin initially, and is compatible with long-term management through lifestyle and oral medications in many people. But these management differences do not reflect less serious pathophysiology — they reflect that the insulin-producing beta cells are (early in the disease) still partially functional, rather than completely destroyed as in Type 1. The long-term complication risk is equally real for poorly managed Type 2 diabetes. Our comparative guide on Type 1 vs Type 2 diabetes explains the actual differences in detail.

Myth 6: Needing Insulin Means You Have Failed at Managing Your Diabetes

The reality: Insulin is a medication, like any other medication. Needing it to manage Type 2 diabetes reflects the natural progression of a chronic disease in which beta cell function declines over time — not a personal failure to eat well, exercise enough, or follow medical advice.

This myth is one of the most damaging in diabetes care, because it causes many people with Type 2 diabetes to refuse insulin even when their blood sugar is dangerously high — preferring to “avoid giving up” rather than accept a medication that would significantly reduce their complication risk. This reluctance has real consequences: suboptimal blood sugar control for months or years while people resist a transition that their beta cells no longer allow them to avoid.

The truth is that beta cell decline in Type 2 diabetes is progressive and largely independent of how well someone manages the modifiable factors. People who exercise regularly, eat well, sleep adequately, and take their medications exactly as prescribed may still need insulin eventually, because their beta cell reserve has declined to the point where oral medications alone cannot maintain acceptable control. Framing insulin as a last resort or a sign of failure is both medically inaccurate and harmful to patients who need it. Insulin is an essential hormone without which neither Type 1 nor advanced Type 2 diabetes can be safely managed.

Myth 7: Diabetes Can Be Cured by Cinnamon, Bitter Melon, or Other Supplements

The reality: No supplement, herb, or natural remedy has been proven in rigorous clinical trials to cure diabetes or produce effects comparable to evidence-based medical treatment. This is one of the most dangerous myths, because it leads people to delay or discontinue effective treatment in favor of unproven alternatives.

Cinnamon has been the subject of multiple small studies showing modest effects on fasting blood sugar, but the results are inconsistent across trials, the effect sizes are small (typically reducing fasting glucose by 3 to 5 percent — far less than what medication achieves), and the quality of evidence is insufficient to support its use as a primary treatment. Bitter melon, berberine, fenugreek, chromium, and magnesium have all been proposed as blood sugar-lowering supplements, and some have modest supporting evidence in small studies. None have been evaluated in the large randomized controlled trials that established the safety and efficacy of approved diabetes medications, and none can substitute for insulin in people who require it.

This does not mean supplements cannot be part of a broader health strategy. Berberine, for example, has reasonable evidence for a modest blood glucose-lowering effect and is used in some clinical settings as an adjunct. But the framing of natural supplements as cures — particularly on social media — is misleading and potentially harmful. Type 2 diabetes remission, which is a real and achievable goal for some people, is achieved through structured dietary intervention and weight loss, not through supplements. And Type 1 diabetes cannot be managed without insulin regardless of what else is tried.

Myth 8: If You Have Diabetes, You Will Definitely Go Blind or Lose a Limb

The reality: These serious complications are real possibilities for people with poorly controlled diabetes — but they are largely preventable with good blood sugar management and regular medical monitoring.

Diabetic retinopathy (eye disease) and peripheral neuropathy (nerve disease leading to foot problems and amputation risk) develop from years of sustained high blood glucose. Research has consistently shown that keeping A1C close to the normal range dramatically reduces the risk of both: the Diabetes Control and Complications Trial (DCCT) in Type 1 diabetes showed that intensive blood sugar control reduced retinopathy development by 76 percent and the progression of kidney disease by 54 percent compared to conventional management. Similar results have been found in Type 2 diabetes.

With regular dilated eye exams, foot examinations, blood pressure control, and consistent blood sugar management, most people with diabetes live their entire lives without significant vision loss or amputation. These outcomes are not inevitable — they are the consequences of long-term uncontrolled hyperglycemia, which modern treatment tools make increasingly avoidable. The key is early diagnosis, access to care, and sustained engagement with blood sugar monitoring. For guidance on what to monitor and how, see our guides on what is blood sugar and home blood sugar monitoring.

Myth 9: People With Diabetes Cannot Exercise

The reality: Exercise is one of the most powerful interventions available for blood sugar management and overall health in people with diabetes — for both Type 1 and Type 2. The American Diabetes Association recommends at least 150 minutes of moderate-intensity aerobic activity per week, plus resistance training twice weekly, as a core component of diabetes care.

For people with Type 1 diabetes, exercise management requires more care — particularly around insulin dose adjustments to prevent hypoglycemia — but is entirely feasible and produces the same cardiovascular and metabolic benefits as in anyone else. Many elite athletes compete at the highest levels in multiple sports with Type 1 diabetes, demonstrating what is possible with good management and modern monitoring tools.

For people with Type 2 diabetes, exercise is particularly powerful because it improves insulin resistance, reduces A1C, supports weight management, improves cardiovascular risk factors, and reduces the risk of diabetes complications. Regular physical activity is often more effective than medication at reducing A1C in the early stages of Type 2 diabetes, and its benefits are additive with medication when both are used together.

Myth 10: Prediabetes Is Not Real or Worth Worrying About

The reality: Prediabetes is a real metabolic condition with real physiological consequences and real clinical implications. It is not a label invented by pharmaceutical companies to increase medication sales (another common claim), and it is not something to dismiss as “borderline” or “almost normal.”

As explained in detail in our guide on what is prediabetes, the condition involves measurable insulin resistance, detectable early-stage glucose toxicity to small blood vessels and nerves, and a significantly elevated cardiovascular risk — all before blood glucose reaches the official diabetes threshold. More importantly, it is also the stage at which lifestyle intervention is most effective at preventing progression. The evidence from the Diabetes Prevention Program — 58 percent reduction in progression to Type 2 diabetes with structured lifestyle changes — is among the strongest in preventive medicine.

Prediabetes is not a sentence. It is a signal — one that arrives early enough for meaningful action. Dismissing it as not worth worrying about squanders the most valuable window of intervention available in the diabetes prevention pathway.

Myth 11: Once You Have Diabetes, There Is Nothing You Can Do

The reality: While neither Type 1 nor Type 2 diabetes is currently curable in the traditional sense, both are highly manageable — and in the case of Type 2, significant improvement and even remission are achievable through lifestyle and medical intervention. The belief that a diabetes diagnosis means inevitable decline and helplessness is both factually wrong and clinically harmful, because it undermines the motivation to make the changes and take the medications that determine long-term outcomes.

For Type 1 diabetes, modern management tools — continuous glucose monitors, insulin pumps with automatic dose adjustments, rapid and long-acting insulin analogs, and increasingly sophisticated hybrid closed-loop systems — have transformed outcomes compared to even twenty years ago. People diagnosed with Type 1 today who have access to current technology and management practices can expect to live full, active lives with substantially lower complication rates than previous generations.

For Type 2 diabetes, the range of intervention is even broader. Structured lifestyle intervention can produce significant A1C reductions, reduce medication requirements, and in some cases achieve remission — returning blood sugar to the non-diabetes range without medication. The DiRECT trial demonstrated remission in approximately 46 percent of participants at one year with a structured low-calorie diet program. Bariatric surgery produces remission in 60 to 80 percent of people with Type 2 diabetes, sometimes within days of the procedure — before significant weight loss has occurred — demonstrating the plasticity of the underlying metabolic condition. There is much that can be done, at every stage of diabetes.

Myth 12: Diabetes Is Contagious

The reality: Diabetes is not contagious. Neither Type 1 nor Type 2 diabetes can be transmitted from one person to another through any form of contact. Type 1 is an autoimmune condition with genetic and environmental triggers; Type 2 is a metabolic condition shaped by genetics, lifestyle, and aging. Neither is caused by any infectious agent that could spread between people.

This myth may seem obvious to many readers, but it persists in some communities and contributes to social isolation and stigma for people living with diabetes. Children with Type 1 diabetes occasionally face exclusion from activities or avoidance by other families based on this misconception. Dispelling it clearly matters for the social inclusion and wellbeing of people with the condition.

Myth 13: Thin People Do Not Need to Worry About Diabetes

The reality: As discussed in Myth 2, Type 2 diabetes occurs across the full weight spectrum, including in people with normal or low BMI. Additionally, Type 1 diabetes — which affects people at all body sizes — often goes undiagnosed for longer in adults because clinicians assume that a lean adult who develops glucose intolerance must have Type 2, leading to incorrect treatment that withholds necessary insulin.

The “thin-fat” phenotype — people who are metabolically at-risk despite normal body weight due to high visceral fat, low muscle mass, and genetic factors affecting insulin sensitivity — is particularly common in Asian populations and is not captured by BMI screening. Diabetes risk assessment should consider multiple factors including family history, activity level, waist circumference, blood pressure, and fasting blood sugar, rather than relying solely on body weight as a proxy for metabolic health.

Why These Myths Matter: The Real Cost of Misinformation

The myths covered in this guide are not merely intellectual errors — they have measurable consequences for health outcomes. Research on diabetes stigma has documented that people who internalize blame for their condition — believing that they “gave themselves” diabetes through laziness or poor choices — show worse medication adherence, lower rates of seeking medical care, poorer psychological wellbeing, and higher rates of depression and diabetes burnout.

Stigma also affects clinical care: healthcare providers who hold implicit biases about lifestyle-caused disease may offer less empathetic care, make fewer referrals, or inadvertently communicate judgment through word choice. Language matters: the difference between “you have uncontrolled diabetes” and “your blood sugar has been running high” conveys the same clinical information with very different emotional implications.

The antidote to these myths is accurate, accessible information about what diabetes actually is, why it develops, how it is managed, and what determines outcomes. The more clearly people understand the biology — how the body regulates blood sugar, what insulin is and does, why cells develop resistance, and how complications are prevented — the more effectively they can engage with their own health and support those around them managing the condition. Every myth replaced by accurate understanding is a small step toward better health outcomes and a kinder, more informed public conversation about one of the most consequential health challenges of our time.

Sources: American Diabetes Association. Standards of Medical Care in Diabetes — 2024. Diabetes Care. 2024;47(Suppl 1):S20–S42. • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329(14):977–986. • Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346(6):393–403.